UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in an In Vitro Infection Model

Antimicrobial Agents and Chemotherapy, 2013-06, Vol.57 (6), p.2809-2814

2013

Volltextzugriff (PDF)

Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with Ceftolozane

Antimicrobial Agents and Chemotherapy, 2013-12, Vol.57 (12), p.5924-5930

2013

Volltextzugriff (PDF)

First observation of fouling of externally attached radio transmitters in an African river

Water S. A., 2020-10, Vol.46 (4), p.672-674

2020

Volltextzugriff (PDF)

Clinical Experience with Daptomycin for the Treatment of Patients with Osteomyelitis

The American journal of medicine, 2007-10, Vol.120 (10), p.S13-S20

2007

Volltextzugriff (PDF)

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model

Antimicrobial agents and chemotherapy, 2016-04, Vol.60 (4), p.2075-2080

2016

Volltextzugriff (PDF)

Relationship between Ceftolozane-Tazobactam Exposure and Drug Resistance Amplification in a Hollow-Fiber Infection Model

Antimicrobial Agents and Chemotherapy, 2013-09, Vol.57 (9), p.4134-4138

2013

Volltextzugriff (PDF)

Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: A retrospective cohort study utilizing the Cubicin® Outcomes Registry and Experience

Clinical therapeutics, 2009-09, Vol.31 (9), p.1936-1945

2009

Volltextzugriff (PDF)

Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection model

Antimicrobial agents and chemotherapy, 2014-10, Vol.58 (10), p.6024-6031

2014

Volltextzugriff (PDF)

Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone β-Lactamase Inhibitor

Antimicrobial agents and chemotherapy, 2017-12, Vol.61 (12)

2017

Volltextzugriff (PDF)

Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection Model

Antimicrobial agents and chemotherapy, 2016-07, Vol.60 (7), p.3891-3896

2016

Volltextzugriff (PDF)

Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE)

International journal of antimicrobial agents, 2009-06, Vol.33 (6), p.543-548

2009

Volltextzugriff (PDF)

Combinatorial Pharmacodynamics of Ceftolozane-Tazobactam against Genotypically Defined β-Lactamase-Producing Escherichia coli: Insights into the Pharmacokinetics/Pharmacodynamics of β-Lactam-β-Lactamase Inhibitor Combinations

Antimicrobial agents and chemotherapy, 2016-04, Vol.60 (4), p.1967-1973

2016

Volltextzugriff (PDF)

In vitro pharmacodynamic evaluation of ceftolozane/tazobactam against β-lactamase-producing escherichia coli in a hollow-fibre infection model

International journal of antimicrobial agents, 2017-01, Vol.49 (1), p.25-30

2017

Volltextzugriff (PDF)

Postmarketing Clinical Experience in Patients with Skin and Skin-Structure Infections Treated with Daptomycin

The American journal of medicine, 2007-10, Vol.120 (10), p.S6-S12

2007

Volltextzugriff (PDF)

Cubicin Outcomes Registry and Experience (CORE) Methodology

The American journal of medicine, 2007-10, Vol.120 (10), p.S4-S5

2007

Volltextzugriff (PDF)

Daptomycin in the Treatment of Bacteremia

The American journal of medicine, 2007-10, Vol.120 (10), p.S21-S27

2007

Volltextzugriff (PDF)

Fatal Hypoglycemia Associated with Levofloxacin

Pharmacotherapy, 2004-12, Vol.24 (12), p.1807-1812

2004

Volltextzugriff (PDF)

Comparison of methods of interpretation of checkerboard synergy testing

Diagnostic microbiology and infectious disease, 2002-12, Vol.44 (4), p.363-366

2002

Volltextzugriff (PDF)

Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001–05

Journal of antimicrobial chemotherapy, 2007-10, Vol.60 (4), p.788-794

2007

Volltextzugriff (PDF)

Clinical experience with daptomycin for the treatment of patients with documented gram-positive septic arthritis

The Annals of pharmacotherapy, 2008-02, Vol.42 (2), p.213-217

2008

Volltextzugriff (PDF)

Clinical experience with daptomycin treatment of foot or ankle osteomyelitis : A preliminary study

Clinical orthopaedics and related research, 2007-08, Vol.461 (461), p.35-39

2007

Volltextzugriff (PDF)

Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods

Diagnostic microbiology and infectious disease, 2000-09, Vol.38 (1), p.43-50

2000

Volltextzugriff (PDF)

Determination of Antibiotic Effect in an In Vitro Pharmacodynamic Model: Comparison with an Established Animal Model of Infection

Antimicrobial Agents and Chemotherapy, 2002-11, Vol.46 (11), p.3574-3579

2002

Volltextzugriff (PDF)

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae

Antimicrobial agents and chemotherapy, 2023-04, Vol.67 (4), p.e0221321-e0221321

2023

Volltextzugriff (PDF)

Impact of Use of Multiple Antimicrobials on Changes in Susceptibility of Gram-Negative Aerobes

Clinical infectious diseases, 1999-05, Vol.28 (5), p.1017-1024

1999

Volltextzugriff (PDF)

1 – 25 von 559

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(499)
Mit Volltextzugriff
(505)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(555)
Deutsch
(4)
Afrikaans
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(259)
Life Sciences & Biomedicine
(160)
Physics Of Elementary Particles And Fields
(131)
Humans
(108)
Physical Sciences
(86)
Physics
(74)
Biological And Medical Sciences
(69)
Male
(67)
Medical Sciences
(62)
Female
(58)
Adult
(43)
Animals
(43)
Middle Aged
(41)
Aged
(34)
Microbiology
(33)
Pharmacology & Pharmacy
(30)
Physics, Applied
(27)
Pharmacology. Drug Treatments
(25)
Urology & Nephrology
(24)
Astronomy & Astrophysics
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in an In Vitro Infection Model

Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with Ceftolozane

First observation of fouling of externally attached radio transmitters in an African river

Clinical Experience with Daptomycin for the Treatment of Patients with Osteomyelitis

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model

Relationship between Ceftolozane-Tazobactam Exposure and Drug Resistance Amplification in a Hollow-Fiber Infection Model

Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: A retrospective cohort study utilizing the Cubicin® Outcomes Registry and Experience

Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection model

Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone β-Lactamase Inhibitor

Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection Model

Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE)

Combinatorial Pharmacodynamics of Ceftolozane-Tazobactam against Genotypically Defined β-Lactamase-Producing Escherichia coli: Insights into the Pharmacokinetics/Pharmacodynamics of β-Lactam-β-Lactamase Inhibitor Combinations

In vitro pharmacodynamic evaluation of ceftolozane/tazobactam against β-lactamase-producing escherichia coli in a hollow-fibre infection model

Postmarketing Clinical Experience in Patients with Skin and Skin-Structure Infections Treated with Daptomycin

Cubicin Outcomes Registry and Experience (CORE) Methodology

Daptomycin in the Treatment of Bacteremia

Fatal Hypoglycemia Associated with Levofloxacin

Comparison of methods of interpretation of checkerboard synergy testing

Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001–05

Clinical experience with daptomycin for the treatment of patients with documented gram-positive septic arthritis

Clinical experience with daptomycin treatment of foot or ankle osteomyelitis : A preliminary study

Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods

Determination of Antibiotic Effect in an In Vitro Pharmacodynamic Model: Comparison with an Established Animal Model of Infection

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae

Impact of Use of Multiple Antimicrobials on Changes in Susceptibility of Gram-Negative Aerobes

Suchergebnisse filtern